Further evidence for the use of aspirin in COVID-19.

Tantry, Udaya S; Bliden, Kevin P; Gurbel, Paul A

Tantry, Udaya S; Bliden, Kevin P; Gurbel, Paul A.

Tantry US; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, MD, USA. Electronic address: Utantry@lifebridgehealth.org.
Bliden KP; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, MD, USA.
Gurbel PA; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, MD, USA.

Int J Cardiol ; 346: 107-108, 2022 01 01.

Article in English | MEDLINE | ID: covidwho-1587662

Subject(s)

Aspirin; COVID-19; Aspirin/adverse effects; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Aspirin / COVID-19 Limits: Humans Language: English Journal: Int J Cardiol Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google